Advertisement
Heart, Lung and Circulation

Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome

Published:April 12, 2016DOI:https://doi.org/10.1016/j.hlc.2016.02.023

      Background

      We aimed to investigate the usefulness of monocyte to HDL cholesterol ratio (MHR) in predicting coronary artery disease severity and future major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS).

      Methods

      2661 patient with ACS were enrolled and followed up during median 31.6 months.

      Results

      MHR were significantly positively correlated with neutrophil to lymphocyte ratio (r = 0.438), CRP (r = 0.394), Gensini (r = 0.407), and SYNTAX score (r = 0.333). During in-hospital and long-term follow-up, MACE, stent thrombosis, non-fatal MI, and mortality occurred more frequently in the third tertile group. Kaplan-Meier analysis revealed the higher occurrence of MACE in the third tertile group compared with other tertiles. Adjusting for other factors, a MHR value in the third tertile group was determined as an independent predictor of in-hospital and long-term MACE.

      Conclusions

      MHR as a novel inflammation-based marker seemed to be an independent predictor of severity of coronary artery disease and future cardiovascular events in patients with ACS. MHR may utilise the identification of patients who are at higher risk for MACE and individualisation of targeted therapy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ancuta P.
        • Wang J.
        • Gabuzda D.
        CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells.
        J. Leukoc. Biol. 2006; 80: 1156-1164
        • Parthasarathy S.
        • Barnett J.
        • Fong L.G.
        High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
        Biochim. Biophys. Acta. 1990; 1044: 275-283
        • Westerterp M.
        • Gourion-Arsiquaud S.
        • Murphy A.J.
        • Shih A.
        • Cremers S.
        • Levine R.L.
        • et al.
        Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways.
        Cell Stem Cell. 2012; 11: 195-206
        • Wang N.
        • Lan D.
        • Chen W.
        • Matsuura F.
        • Tall A.R.
        ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
        Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 9774-9779
        • Kanbay M.
        • Solak Y.
        • Unal H.U.
        • Kurt Y.G.
        • Gok M.
        • Cetinkaya H.
        • et al.
        Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.
        Int. Urol. Nephrol. 2014; 46: 1619-1625
        • Canpolat U.
        • Aytemir K.
        • Yorgun H.
        • Şahiner L.
        • Kaya E.B.
        • Çay S.
        • et al.
        The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation.
        Europace. 2015; 17: 1807-1815
        • Canpolat U.
        • Çetin E.H.
        • Cetin S.
        • Aydin S.
        • Akboga M.K.
        • Yayla C.
        • et al.
        Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation.
        Clin. Appl. Thromb. Hemost. 2015;
        • Cetin E.H.O.
        • Cetin M.S.
        • Canpolat U.
        • Aydin S.
        • Topaloglu S.
        • Aras D.
        • et al.
        Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
        Biomark. Med. 2015; 9: 967-977
        • Karataş M.B.
        • Çanga Y.
        • Özcan K.S.
        • İpek G.
        • Güngör B.
        • Onuk T.
        • et al.
        Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
        Am. J. Emerg. Med. 2015;
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Simoons M.L.
        • Chaitman B.R.
        • White H.D.
        • et al.
        Third universal definition of myocardial infarction.
        J. Am. Coll. Cardiol. 2012; 60: 1581-1598
        • Thygesen K.
        • Alpert J.S.
        • White H.D.
        Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction.
        J. Am. Coll. Cardiol. 2007; 50: 2173-2195
        • Hamm C.W.
        • Bassand J.-P.
        • Agewall S.
        • Bax J.
        • Boersma E.
        • Bueno H.
        • et al.
        ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio.
        Eur. Heart J. 2011; 32: 2999-3054
        • Bassand J.-P.
        • Hamm C.W.
        • Ardissino D.
        • Boersma E.
        • Budaj A.
        • Fernández-Avilés F.
        • et al.
        Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.
        Eur. Heart J. 2007; 28: 1598-1660
        • Cutlip D.E.
        • Windecker S.
        • Mehran R.
        • Boam A.
        • Cohen D.J.
        • van Es G.-A.
        • et al.
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Ghattas A.
        • Griffiths H.R.
        • Devitt A.
        • Lip G.Y.H.
        • Shantsila E.
        Monocytes in coronary artery disease and atherosclerosis: where are we now?.
        J. Am. Coll. Cardiol. 2013; 62: 1541-1551
        • Mestas J.
        • Ley K.
        Monocyte-endothelial cell interactions in the development of atherosclerosis.
        Trends Cardiovasc. Med. 2008; 18: 228-232
        • Woollard K.J.
        • Geissmann F.
        Monocytes in atherosclerosis: subsets and functions.
        Nat. Rev. Cardiol. 2010; 7: 77-86
        • Qiao J.H.
        • Tripathi J.
        • Mishra N.K.
        • Cai Y.
        • Tripathi S.
        • Wang X.P.
        • et al.
        Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
        Am. J. Pathol. 1997; 150: 1687-1699
        • Palmerini T.
        • Coller B.S.
        • Cervi V.
        • Tomasi L.
        • Marzocchi A.
        • Marrozzini C.
        • et al.
        Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system.
        J. Am. Coll. Cardiol. 2004; 44: 1570-1577
        • Murphy A.J.
        • Woollard K.J.
        High-density lipoprotein: a potent inhibitor of inflammation.
        Clin. Exp. Pharmacol. Physiol. 2010; 37: 710-718
        • Murphy A.J.
        • Woollard K.J.
        • Hoang A.
        • Mukhamedova N.
        • Stirzaker R.A.
        • McCormick S.P.A.
        • et al.
        High-density lipoprotein reduces the human monocyte inflammatory response.
        Arterioscler. Thromb. Vasc. Biol. 2008; 28: 2071-2077
        • Cutlip D.E.
        • Baim D.S.
        • Ho K.K.
        • Popma J.J.
        • Lansky A.J.
        • Cohen D.J.
        • et al.
        Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.
        Circulation. 2001; 103: 1967-1971
        • van der Laan A.M.
        • Hirsch A.
        • Robbers L.F.H.J.
        • Nijveldt R.
        • Lommerse I.
        • Delewi R.
        • et al.
        A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.
        Am. Heart J. 2012; 163 (57–65.e2)
        • Kontush A.
        • Chapman M.J.
        Antiatherogenic small, dense HDL–guardian angel of the arterial wall?.
        Nat. Clin. Pract. Cardiovasc. Med. 2006; 3: 144-153
        • Boisvert W.A.
        • Black A.S.
        • Curtiss L.K.
        ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
        Arterioscler. Thromb. Vasc. Biol. 1999; 19: 525-530